Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
1.265
-0.965 (-43.27%)
At close: Aug 1, 2025, 4:00 PM
1.270
+0.005 (0.40%)
After-hours: Aug 1, 2025, 7:59 PM EDT
ShockWave Medical Employees
Zynex had 1,000 employees as of December 31, 2024. The number of employees decreased by 100 or -9.09% compared to the previous year.
Employees
1,000
Change (1Y)
-100
Growth (1Y)
-9.09%
Revenue / Employee
$144,808
Profits / Employee
-$28,662
Market Cap
38.25M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,000 | -100 | -9.09% |
Dec 31, 2023 | 1,100 | 200 | 22.22% |
Dec 31, 2022 | 900 | 126 | 16.28% |
Dec 31, 2021 | 774 | 6 | 0.78% |
Dec 31, 2020 | 768 | 485 | 171.38% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ZYXI News
- 2 days ago - Zynex, Inc. (ZYXI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Zynex Reports Second Quarter 2025 Financial Results - PRNewsWire
- 12 days ago - Zynex Sets Second Quarter 2025 Earnings Call - PRNewsWire
- 4 weeks ago - Tricare Temporary Payment Suspension Update - PRNewsWire
- 4 weeks ago - Zynex Announces Steven Dyson as New CEO - PRNewsWire
- 5 weeks ago - Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis - PRNewsWire
- 2 months ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zynex - GlobeNewsWire
- 3 months ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 19, 2025 in Zynex, Inc. Lawsuit – ZYXI - GlobeNewsWire